ArticleScientific reports2026
Posterior reversible encephalopathy syndrome in Colombia a case series.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posterior Reversible Encephalopathy Syndrome (PRES) is a rare clinical and radiological condition. There is limited information regarding the characteristics of PRES in the Colombian population. This study aims to describe the clinical-radiological characteristics of PRES in a series of cases in Colombia. A retrospective study was conducted between 2018 and 2024 with adult patients with PRES in two high complexity centers in Bogota, Colombia. Demographic, clinical, radiological, electroencephalographic, neurological complications and clinical outcomes were registered. Comparison of outcomes was performed between patients with and without neurological complications (ischemia, hemorrhage, or status epilepticus). A bivariate logistic regression analysis was performed to determine the risk factors associated with neurological complications of PRES. We included 60 patients with a median age of 55 years, 68.3% women. The most frequent risk/triggering factor was high systemic blood pressure (55%). Main symptoms reported were seizures (73.3%), impaired consciousness (60%), headache (43.3%) and visual changes (36.6%). Vasogenic cerebral edema was more common in the occipito-parietal region (33.3%). No fatalities were reported. The most frequent neurological complication was intracranial hemorrhage. Absence of complications was associated with shorter hospital stay (6 vs. 14 days). Additionally, a history of cerebrovascular disease and decreased visual acuity at presentation were associated with a lower observed rate of neurological complications following PRES (OR 0.1; 95% CI 0.01–0.91). Clinical-radiological characteristics of PRES in the Colombian population studied are similar to those described in literature. In our analysis, a history of cerebrovascular disease and decreased visual acuity at presentation were associated with a lower observed rate of neurological complications following PRES.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.